Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Harirforoosh, S."'
Publikováno v:
ETSU Faculty Works.
BACKGROUND: Numerous methods have been devised to combat human immunodeficiency virus (HIV) replication and disease progression. Composed of an integrase strand transfer inhibitor, a pharmacoenhancer, and two reverse transcriptase inhibitors, Stribil
Externí odkaz:
https://dc.etsu.edu/etsu-works/15624
https://dc.etsu.edu/cgi/viewcontent.cgi?article=16890&context=etsu-works
https://dc.etsu.edu/cgi/viewcontent.cgi?article=16890&context=etsu-works
Publikováno v:
ETSU Faculty Works.
OBJECTIVE: Niacin, activating G-protein coupled receptor (GPR) 109A, stimulates release of vasodilatory prostaglandins (PGs) such as PGE2 which can elicit niacin-associated flushing side effects. Poly-lactic-coglycolic acid (PLGA) and poly-lactic aci
Externí odkaz:
https://dc.etsu.edu/etsu-works/15490
https://dc.etsu.edu/cgi/viewcontent.cgi?article=16756&context=etsu-works
https://dc.etsu.edu/cgi/viewcontent.cgi?article=16756&context=etsu-works
Publikováno v:
ETSU Faculty Works.
OBJECTIVE: Utilization of nonsteroidal anti-inflammatory drugs (NSAIDs), such as diclofenac, can produce gastrointestinal ulceration. Thus, cyclooxygenase-2-selective inhibitors, such as celecoxib, and protective agents (e.g. rebamipide) have been em
Externí odkaz:
https://dc.etsu.edu/etsu-works/15469
https://dc.etsu.edu/cgi/viewcontent.cgi?article=16735&context=etsu-works
https://dc.etsu.edu/cgi/viewcontent.cgi?article=16735&context=etsu-works
Publikováno v:
ETSU Faculty Works.
With the beginning of the Human Genome Project, an emerging field of science was brought to the forefront of the pharmaceutical community. Pharmacogenetics facilitates optimization of the current patient-centered care model and pharmacotherapy as a w
Externí odkaz:
https://dc.etsu.edu/etsu-works/16211
Publikováno v:
ETSU Faculty Works.
OBJECTIVE: Nonsteroidal anti-inflammatory drugs (NSAIDs) are assembled into two categories; cyclooxygenase (COX-1) sparing inhibitors of COX-2 and non-selective NSAIDs. Diclofenac (DICLO) is a non-selective NSAID that has been linked to serious side
Autor:
Harirforoosh, S., West, K. O., Murrell, D. E., Denham, James W., Panus, Peter C., Hanley, G. A.
Publikováno v:
ETSU Faculty Works.
Objective: Celecoxib (CEL) is a nonsteroidal anti-inflammatory drug (NSAID) showing selective cycloxygenase-2 inhibition. While effective as a pain reducer, CEL exerts some negative influence on renal and gastrointestinal parameters. This study exami
Publikováno v:
ETSU Faculty Works.
What is known and objective: Although non-steroidal anti-inflammatory drugs (NSAIDs) have been studied in randomized, controlled trials and meta-analyses in an effort to determine their cardiovascular (CV) risks, no consensus has been reached. These
Externí odkaz:
https://dc.etsu.edu/etsu-works/10840
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Annals of Epidemiology December 2019 40:38-38